| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Market Share Units |
23.4K |
$1.24M |
$52.99 |
10 Mar 2025 |
Direct |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
15.8K |
$1M |
$63.11 |
10 Mar 2025 |
Direct |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
11.3K |
$609K |
$53.79 |
10 Mar 2024 |
Direct |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
2.1K |
$132K |
$63.11 |
10 Mar 2025 |
BMS Savings and Investment Program |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
1.66K |
$89.1K |
$53.79 |
10 Mar 2024 |
BMS Savings and Investment Program |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
200 |
$12.6K |
$63.11 |
10 Mar 2025 |
Family Trust |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Common Stock, $0.10 par value |
200 |
$10.8K |
$53.79 |
10 Mar 2024 |
Family Trust |
| BRISTOL MYERS SQUIBB CO |
EVP, Chief Research Officer |
Performance Shares |
35.1K |
|
|
10 Mar 2025 |
Direct |
| Translate Bio, Inc. |
Director |
Stock Option (right to buy) |
0 |
|
|
14 Sep 2021 |
Direct |